|
New York, NY, November 18, 2009-Ebitda News reports that EBITDA for PDL BioPharma, Inc. (NASDAQ:PDLI) for its twelve months ended September 30, 2009 was $305,216,000, a 696% increase over the year ear ... read full story |
|
| Website Address: |
www.pdl.com |
| Industry: |
Vaccine, Antibodies, Immunities
|
|